Pulido, T., Adzerikho, I., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H.-A., … Simonneau, G. (2013). Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. New England Journal of Medicine, 369(9), 809–818. https://doi.org/10.1056/nejmoa1213917

Pulido, Tomás, Igor Adzerikho, Richard N. Channick, Marion Delcroix, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Pavel Jansa, et al. “Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension.” New England Journal of Medicine 369, no. 9 (August 29, 2013): 809–18. https://doi.org/10.1056/nejmoa1213917.

Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, et al. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. New England Journal of Medicine. 2013 Aug 29;369(9):809–18.

Pulido, Tomás, et al. “Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension.” New England Journal of Medicine, vol. 369, no. 9, Massachusetts Medical Society, Aug. 2013, pp. 809–18. Crossref, doi:10.1056/nejmoa1213917.

Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani H-A, Jansa P, Jing Z-C, Le Brun F-O, Mehta S, Mittelholzer CM, Perchenet L, Sastry BKS, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension. New England Journal of Medicine. Massachusetts Medical Society; 2013 Aug 29;369(9):809–818.